Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013034 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Liyan Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Single-Domain Antibodies, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
The persistent emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants highlights the need for developing broad-spectrum antiviral agents. Here, we report the identification of two sarbecovirus S2-specific alpaca nanobodies, namely H17 and H145, that effectively neutralize known SARS-CoV-2 variants (including the Omicron subvariants) and other sarbecoviruses (such as SARS-CoV, PANG/GD, WIV1, and HKU3). The two nanobodies recognize a linear epitope (D 1139 PLQPELDSFKEEL 1152 ) in the upper region of the S2 stem-helix (SH), which is highly conserved among SARS-CoV-2 variants and other sarbecoviruses. The complex structure of the nanobody bound to the epitope SH-peptide reveal that nanobody binding will impede the refolding of S2, effectively neutralizing the virus. Moreover, the nanobodies bind viral S2 in an acidification-insensitive manner, demonstrating their capacity for entry inhibition especially when viruses enter via the endosomal route. Finally, H17 and H145 possess a better taking-action window for virus neutralization, superior to the RBD-targeting nanobodies that exert neutralization by competing against ACE2 binding. Taken together, the results suggest that anti-SH nanobodies H17 and H145 are promising broad-spectrum drug candidates for preventing and treating the pandemic infections by SARS-CoV-2 variants and other sarbecoviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Disaster Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- School of Basic Medical Sciences, Chengdu University, Chengdu, Sichuan China.
- College of Food and Biological Engineering, Chengdu University, Chengdu, Sichuan China.
ORCID-Profile: Guangwen Lu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- West China Hospital, Sichuan University
- Natural Science Foundation of Sichuan Province, China
- National Postdoctoral Program for Innovative Talents of China
- 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
- Natural Science Foundation of Sichuan Province
- National Postdoctoral Program for Innovative Talents
Zitieren
APA
Guo, L., Chen, Z., Lin, S., Yang, F., Yang, J., Wang, L., Zhang, X., Yuan, X., He, B., Cao, Y., Li, J., Zhao, Q., & Lu, G. (2025). Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013034
Vancouver
Guo L, Chen Z, Lin S, Yang F, Yang J, Wang L, et al. Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013034
BibTeX
@article{Guo2025,
author = {Guo, Liyan and Chen, Zimin and Lin, Sheng and Yang, Fanli and Yang, Jing and Wang, Lingling and Zhang, Xindan and Yuan, Xin and He, Bin and Cao, Yu and Li, Jian and Zhao, Qi and Lu, Guangwen},
title = {Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013034}
}
EUVIMED